194 related articles for article (PubMed ID: 28353226)
1. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
[TBL] [Abstract][Full Text] [Related]
2. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.
Galicia N; Dégano R; Díez P; González-González M; Góngora R; Ibarrola N; Fuentes M
Expert Rev Proteomics; 2017 Apr; 14(4):363-372. PubMed ID: 28293970
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
[TBL] [Abstract][Full Text] [Related]
4. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer.
Bach F; Bach FW; Pedersen AG; Larsen PM; Dombernowsky P
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1703-9. PubMed ID: 2632253
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia.
Millot F; Dhondt JL; Mazingue F; Mechinaud F; Auget JL; Bauters F; Harousseau JL
Leuk Lymphoma; 1993 Mar; 9(4-5):351-6. PubMed ID: 8348070
[TBL] [Abstract][Full Text] [Related]
7. HMFG1 antigen: a new marker for carcinomatous meningitis.
Moseley RP; Oge K; Shafqat S; Moseley CM; Sullivan NM; Badley RA; Burchell J; Taylor-Papadimitriou J; Coakham HB
Int J Cancer; 1989 Sep; 44(3):440-4. PubMed ID: 2777410
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal carcinomatosis and cranial nerve palsy as presenting symptoms of a clinically inapparent gallbladder carcinoma.
Gaumann A; Marx J; Bohl J; Kommoss F; Köhler H; Tews DS
Pathol Res Pract; 1999; 195(7):495-9. PubMed ID: 10448666
[TBL] [Abstract][Full Text] [Related]
9. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Groves MD
Neurology; 2006 May; 66(10):1609-10; author reply 1609-10. PubMed ID: 16717241
[No Abstract] [Full Text] [Related]
10. Leptomeningeal carcinomatosis: review of the literature.
Iaconetta G; Lamaida E; Rossi A; Signorelli F; Manto A; Giamundo A
Acta Neurol (Napoli); 1994 Aug; 16(4):214-20. PubMed ID: 7856476
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer with isolated leptomeningeal metastases: a case report.
Sambasivaiah K; Reddy K; Lakshmi AY; Menon B; Varma VS
Trop Gastroenterol; 2007; 28(1):39-40. PubMed ID: 17896611
[TBL] [Abstract][Full Text] [Related]
12. CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases.
Brandsma D; Voest EE; de Jager W; Bonfrer H; Algra A; Boogerd W; Korse T; Reijneveld JC; Verbeek MM; Rijkers G; Taphoorn MJ
J Neurol; 2006 Sep; 253(9):1177-84. PubMed ID: 16998648
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies.
Schmid D; Warnken U; Latzer P; Hoffmann DC; Roth J; Kutschmann S; Jaschonek H; Rübmann P; Foltyn M; Vollmuth P; Winkler F; Seliger C; Felix M; Sahm F; Haas J; Reuss D; Bendszus M; Wildemann B; von Deimling A; Wick W; Kessler T
J Neurochem; 2021 Jul; 158(2):522-538. PubMed ID: 33735443
[TBL] [Abstract][Full Text] [Related]
14. [Meningeal carcinomatosis].
Baiges-Octavio JJ; Huerta-Villanueva M
Rev Neurol; 2000 Dec 16-31; 31(12):1237-41. PubMed ID: 11205566
[TBL] [Abstract][Full Text] [Related]
15. Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF, MALDI-FTICR and nanoLC-FTICR MS.
Römpp A; Dekker L; Taban I; Jenster G; Boogerd W; Bonfrer H; Spengler B; Heeren R; Smitt PS; Luider TM
Proteomics; 2007 Feb; 7(3):474-81. PubMed ID: 17274072
[TBL] [Abstract][Full Text] [Related]
16. Leptomeningeal metastasis from prostate cancer.
Cante D; Franco P; Sciacero P; Girelli G; Casanova Borca V; Pasquino M; Migliaccio F; Tofani S; Grassi L; Marra A; Ozzello F; La Porta MR; Ricardi U
Tumori; 2013; 99(1):6e-10e. PubMed ID: 23549020
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.
Hovestadt A; Henzen-Logmans SC; Vecht CJ
Br J Cancer; 1990 Oct; 62(4):653-4. PubMed ID: 2223585
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
Lin X; Fleisher M; Rosenblum M; Lin O; Boire A; Briggs S; Bensman Y; Hurtado B; Shagabayeva L; DeAngelis LM; Panageas KS; Omuro A; Pentsova EI
Neuro Oncol; 2017 Sep; 19(9):1248-1254. PubMed ID: 28821205
[TBL] [Abstract][Full Text] [Related]
19. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
Bach F; Soletormos G; Dombernowsky P
J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
